Cancer guide
By Cura Editorial Team ·
The leading cause of cancer death in the US — early detection with low-dose CT and biomarker-driven treatment have changed the outlook dramatically.
Early signs, which ones need a same-week doctor visit, and what screening looks like.
Read the symptoms guideThe questions that shape treatment — biomarkers, staging, surgery, chemo, second opinions.
Read the questions guideRecent approvals and trial results — and the questions to ask your oncologist about whether any of it applies to you. Not every option fits every person.
The FDA granted accelerated approval to Datroway for advanced EGFR-mutant lung cancer that grew after EGFR-targeted therapy and chemotherapy.
May apply to: EGFR-mutant advanced non-small cell lung cancer, previously treated
Ask your oncologist:
Source: FDA
The FDA approved zidesamtinib (Jideytro) for advanced ROS1-positive lung cancer after at least one prior ROS1-targeted drug.
May apply to: ROS1-positive advanced non-small cell lung cancer
Ask your oncologist:
Source: FDA
Reviewed September 25, 2026.
Email me when something new is approved for lung cancer
Only real treatment news for this cancer, in plain language. Optional — the guide and Ask Cura stay free and anonymous. Unsubscribe anytime.
The signs that most often lead to a lung cancer diagnosis are: a cough that lasts more than 3 weeks or changes character; coughing up blood, even once; unexplained shortness of breath, chest pain, or weight loss. Any of these lasting more than a couple of weeks is worth a same-week appointment, even though most turn out to be something else.
See a doctor promptly if a symptom is new, persistent, or getting worse rather than better. Describe when it started, how often it happens, and what makes it better or worse — that detail is what decides whether you get imaging or testing at the first visit.
The leading cause of cancer death in the US — early detection with low-dose CT and biomarker-driven treatment have changed the outlook dramatically. Low-dose CT screening is recommended for adults 50–80 with a significant smoking history. Biomarker testing (EGFR, ALK, ROS1, KRAS, PD-L1) is now standard. About 10–20% of lung cancers occur in people who never smoked.
Ask what the exact diagnosis is and how it is staged, what the treatment options are and in what order they would happen, what the goal of treatment is, which side effects to expect, and whether a second opinion or clinical trial makes sense for your situation.
Paste a pathology report, upload a scan summary, or just type the question you'd ask your oncologist if you had more than 15 minutes. Cura will answer in plain language.
Ask CuraWant occasional plain-language health explainers?
A short note now and then. No spam, unsubscribe anytime.
If a start date is on the calendar, or you feel lost between diagnosis and the first infusion, build a first-visit brief on the page: what's known, what's missing, what to ask. Homework, not a treatment plan.
Cura Brief is educational. It is not medical advice, a diagnosis, or a treatment plan. Confirm everything with your oncology team. If this is an emergency, call emergency services. Email is not an emergency line.
Prefer email? hello@curawellplan.com
Waiting for results is its own kind of hard. Cura has a plain-language guide to what the wait actually means — and what to do while you wait.
How long do biopsy results take?